Abstract
A substantial proportion of women with breast cancer exhibit an abnormally high radiosensitivity as measured by the frequency of chromatid breaks induced in G2-phase, PHA stimulated lymphocytes. Chromatid break frequencies were compared for a cohort of previously untreated sporadic breast cancer patients and hospital outpatient controls. In the breast cancer group 46% showed high radiosensitivity compared to 14% of controls (P< 0.001). Comparison of those breast cancer patients with a high G2radiosensitivity (G2RS) versus those with a low G2RS showed no difference in menopausal status or age but the high G2RS group had on average a lower score on the Nottingham Prognostic Index. Predicted survival in the high G2RS group at 15 years was 55% compared to 36% for the low G2RS group. Furthermore, 81% of tumours from the high G2RS were oestrogen receptor positive compared to 45% from the low G2RS group. Thus high G2RS identifies a sub-population of patients with distinctive tumour characteristics and with a predicted improved prognosis as compared with those in the low G2RS group. Our findings imply that besides influencing risk of breast cancer the genetic factors determining G2radiosensitivity also influence the tumour characteristics and prognosis in these patients. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Balslev I, Axelsson CK, Zedeler K, Rasmussen BB, Carstensen B and Mouridsen HT (1994) The Nottingham Prognostic Index applied to 9149 patients from the studies of the Danish Breast Cancer Co-operative Group. Breast Cancer Res Treat 32: 281–290
Brown JM, Benson EA and Jones M (1993) Confirmation of a long-term prognostic index in breast cancer. Breast 2: 144–147
Bryant PE (1998) The signal model: a possible explanation for the conversion of DNA double-strand breaks into chromatid breaks. Int J Radiat Biol 73: 243–251
Chen PL, Sellers TA, Rich SS, Potter JD and Folsom AR (1995) Segregation analysis of breast cancer in a population-based sample of postmenopausal probands. Genet Epidemiol 12: 401–415
Galea MH, Blamey RW, Elston CE and Ellis IOI (1992) The Nottingham prognostic index in primary breast cancer. Breast Cancer Res Treat 22: 207–219
Houlston RS and Peto J (1996) Genetics and the common cancers. In: Genetic Predisposition to Cancer, Eeles RA, Ponder BAJ, Easton DF et al (eds) pp. 208–226, Chapman and Hall: London
Kinzler KW and Vogelstein B (1997) Gatekeepers and caretakers. Nature 386: 761–763
Lakhani SR, Easton DF and Stratton MR the Breast Cancer Linkage Consortium (1997) Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet 349: 1505–1510
Lakhani SR, Jacquemier J, Sloane JP, Gusterson BA, Anderson TJ, van de Vijver MJ, Farid LM, Venter D, Antoniou A, Storfer-Isser A, Smyth E, Steel CM, Haites N, Scott RJ, Goldgar D, Neuhausen S, Daly PA, Ormiston W, McManus R, Scherneck S, Ponder BA, Ford D, Peto J, Stoppa-Lyonnet D and Easton DF (1998) Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 90: 1138–1145
Lakhani SR, Gusterson BA, Jacquemier J, Sloane JP, Anderson TJ, van de Vijver MJ, Venter D, Freeman A, Antoniou A, McGuffog L, Smyth E, Steel CM, Haites N, Scott RJ, Goldgar D, Neuhausen S, Daly PA, Ormiston W, McManus R, Scherneck S, Ponder BA, Futreal PA, Peto J, Stoppa-Lyonnet D, Bignon YJ and Stratton MR (2000) The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Clin Cancer Res 6: 782–789
Parshad R, Price FM, Bohr VA, Cowans KH, Zujewski JA and Sanford KK (1996) Deficient DNA repair capacity, a predisposing factor in breast cancer. Br J Cancer 74: 1–5
Patel RK, Trivedi AH, Arora DC, Bhatavdekar JM and Patel DD (1997) DNA repair proficiency in breast cancer patients and their first-degree relatives. Int J Cancer 73: 20–24
Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, Evans C, Deacon J and Stratton M (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91: 943–949
Roberts SA, Spreadborough AR, Bulman B, Barber JBP, Evans DGR and Scott D (1999) Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer?. Am J Hum Genet 65: 784–794
Rogers-Bald M, Sargent RG and Bryant PE (2000) Production of chromatid breaks by single dsb: evidence supporting the signal model. Int J Radiat Biol 76: 23–29
Sanford KK, Parshad R, Gantt R, Tarone RE, Jones GM and Price FM (1989) Factors affecting and significance of G2chromatin radiosensitivity in predisposition to cancer. Int J Radiat Biol 55: 963–981
Scott D, Spreadborough A, Levine E, Levine E and Roberts SA (1994) Genetic predisposition in breast cancer. Lancet 344: 1444
Scott D, Spreadborough AR, Jones LA, Roberts SA and Moore CJ (1996) Chromosomal radiosensitivity in G2-phase lymphocytes as an indicator of cancer predisposition. Radiat Res 145: 3–16
Scott D, Barber JBP, Levine EL, Burrill W and Roberts SA (1998) Radiation-induced micronucleus induction in lymphocytes identifies a high frequency of radiosensitive cases among breast cancer patients: a test for predisposition. Br J Cancer 77: 614–620
Scott D, Barber JBP, Spreadborough AR, Burrill W and Roberts SA (1999) Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays. Int J Radiat Biol 75: 1–10
Taylor AR (1983) The effects of radiation on the chromosomes of patients with an unusual cancer susceptibility. In: Radiation induced chromosome damage in man, Ishihar T, Sasaki M (eds) pp 167–199, Alan R Liss: New York
Teare MD, Wallace JA, Harris M, Howell A and Birch JM (1994) Cancer experience in the relatives of an unselected series of breast cancer patients. Br J Cancer 10: 102–111
Terzoudi GI, Jung T, Hain J, Vrouvas J, Margaritis K, Donta-Bakoyianni C, Makropoulos V, Angelakis PH and Pantellas GE (2000) Increased G2chromosomal radiosensitivity in cancer patients: the role of cdk 1/cyclin-B activity level in the mechanisms involved. Int J Radiat Biol 76: 607–615
Wang JYL (2000) New link in a web of human genes. Nature 405: 404–405
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Riches, A., Bryant, P., Steel, C. et al. Chromosomal radiosensitivity in G2-phase lymphocytes identifies breast cancer patients with distinctive tumour characteristics. Br J Cancer 85, 1157–1161 (2001). https://doi.org/10.1054/bjoc.2001.2086
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.2086
Keywords
This article is cited by
-
Role of circ-FOXO3 and miR-23a in radiosensitivity of breast cancer
Breast Cancer (2023)
-
Molecular contribution of BRCA1 and BRCA2 to genome instability in breast cancer patients: review of radiosensitivity assays
Biological Procedures Online (2020)
-
Development of a multiparameter flow cytometric assay as a potential biomarker for homologous recombination deficiency in women with high-grade serous ovarian cancer
Journal of Translational Medicine (2015)
-
Gamma-ray-induced mutagen sensitivity and risk of sporadic breast cancer in young women: a case–control study
Breast Cancer Research and Treatment (2012)
-
Association of Rad51 polymorphism with DNA repair in BRCA1 mutation carriers and sporadic breast cancer risk
BMC Cancer (2011)